The New Delhi Metallo-β-lactamase-1 Covalent Inhibitors Derived from Cephalexin Effectively Reverse Meropenem Resistance
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.6c00314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Wandong Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, School of Medicine and Pharmacy, Ocean University of China…. Hauptthemen laut MEDLINE: beta-Lactamase Inhibitors, Meropenem, beta-Lactamases, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Qingdao Marine Science and Technology Center, Ocean University of China.
Abstract (Originalsprache)
New Delhi metallo-β-lactamase-1 (NDM-1) hydrolyzes carbapenems and most β-lactam antibiotics, posing a significant threat to global health and underscoring the urgent need for effective inhibitors. To address this unmet need, we designed a series of covalent NDM-1 inhibitors by introducing a selenazolone warhead into the cephalexin scaffold. Among them, compound 16a demonstrated the most potent inhibitory activity, with an IC50 value of 3.27 μM. The combination of 16a and meropenem (Mem) synergistically lowered the MIC of Mem 8-16-fold in NDM-1-positive isolates and potently suppressed NDM-1-positive bacterial growth in a mouse infection model. Mechanistically, 16a forms a stable Se-S bond with Cys208 at the NDM-1 active site through its selenazolone warhead, enabling prolonged target engagement and sustained enzyme inhibition. Collectively, these findings demonstrate that covalent inhibitors derived from the cephalexin scaffold represent a promising strategy for combating NDM-1-mediated resistance, offering valuable leads for targeting metallo-β-lactamases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266071, China.
- State Key Lab of Chemical Biology and Drug Discovery and the Department of Food Science and Nutrition, The Hong Kong Polytechnic University, Kowloon 100872, Hong Kong, China.
- State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun 130…
ORCID-Profile: Shengbiao Wan, Sheng Chen, Jiazhang Qiu, Rilei Yu
Förderung
- National Natural Science Foundation of China
- Qingdao Marine Science and Technology Center, Ocean University of China
Zitieren
APA
Liu, W., Liu, C., Guo, Y., Liu, Z., Zhang, C., Meng, W., Wan, S., Chen, S., Qiu, J., & Yu, R. (2026). The New Delhi Metallo-β-lactamase-1 Covalent Inhibitors Derived from Cephalexin Effectively Reverse Meropenem Resistance. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c00314
Vancouver
Liu W, Liu C, Guo Y, Liu Z, Zhang C, Meng W, et al. The New Delhi Metallo-β-lactamase-1 Covalent Inhibitors Derived from Cephalexin Effectively Reverse Meropenem Resistance. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c00314
BibTeX
@article{Liu2026,
author = {Liu, Wandong and Liu, Chenyu and Guo, Yan and Liu, Zhiying and Zhang, Chen and Meng, Wanli and Wan, Shengbiao and Chen, Sheng and Qiu, Jiazhang and Yu, Rilei},
title = {The New Delhi Metallo-β-lactamase-1 Covalent Inhibitors Derived from Cephalexin Effectively Reverse Meropenem Resistance},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c00314}
}
EUVIMED